An epidemiological assessment of the distribution and sociodemographic burden of chronic diseases: a focus on hypertension, diabetes, and cardiovascular conditions - Report - MDSpire

An epidemiological assessment of the distribution and sociodemographic burden of chronic diseases: a focus on hypertension, diabetes, and cardiovascular conditions

  • By

  • Chidimma Evangeline Oliobi

  • Dawit Getnet Ayele

  • Knowledge Chinhamu

  • Temesgen Zewotir

  • Retius Chifurira

  • May 22, 2026

  • 0 min

Share

Clinical Report: Epidemiological Analysis of Chronic Disease Prevalence

Overview

This report examines the associations between sociodemographic factors and the prevalence of hypertension, diabetes, and cardiovascular disease (CVD). Key findings indicate that advancing age significantly increases the odds of these conditions, with notable gender differences in diabetes and CVD risk trajectories.

Background

Chronic diseases such as hypertension, diabetes, and CVD are leading contributors to global morbidity and mortality. Their prevalence is particularly concerning among socioeconomically disadvantaged populations, necessitating targeted prevention strategies. Understanding the interplay of sociodemographic factors is crucial for effective public health interventions.

Data Highlights

ConditionAUC
Hypertension0.80
Diabetes0.77
CVD0.83

Key Findings

  • Advancing age is associated with higher odds of hypertension, diabetes, and CVD.
  • Significant age × gender interactions for diabetes and CVD indicate greater risk increases in males.
  • Hypertension risk increases similarly across genders with age.
  • Income and BMI are independently associated with cardiometabolic outcomes.
  • Model discrimination for hypertension, diabetes, and CVD showed good calibration across risk deciles.

Clinical Implications

Healthcare professionals should consider age and gender when assessing cardiometabolic risk in patients. Targeted prevention strategies that account for sociodemographic factors may enhance the effectiveness of interventions.

Conclusion

The findings highlight the importance of sociodemographic factors in the prevalence of chronic diseases, emphasizing the need for tailored public health strategies.

Related Resources & Content

  1. American Heart Association, 2026 Heart Disease and Stroke Statistics - Professional Heart Daily, 2026 -- National prevalence and mortality data
  2. Conexiant, US Heart Health Progress Stalls, 2026 -- Cardiovascular risk factors in the US
  3. European Journal of Preventive Cardiology, The Prospects of Cardiovascular Disease: A Turning Point or Continued Challenge?, 2026 -- Editorial on cardiovascular disease burden
  4. DIGITAL HEALTH — Exploring the impact of digital care delivery for patients with diabetes and hypertension: A longitudinal qualitative study
  5. European Journal of Preventive Cardiology — Addressing the Intersection of Diabetes and Cardiovascular Disease Prevention: Tackling Two Major Health Challenges
  6. Exploring the impact of digital care delivery for patients with diabetes and hypertension
  7. Addressing the Intersection of Diabetes and Cardiovascular Disease Prevention
  8. 2026 Heart Disease and Stroke Statistics - Professional Heart Daily | American Heart Association
  9. Hub - 2025 High Blood Pressure Guideline published in Hypertension - Professional Heart Daily | American Heart Association
  10. U.S. Eligibility and Preventable Cardiovascular, Diabetes, and Kidney Outcomes From Semaglutide in the SELECT Trial | JACC: Advances

Original Source(s)

Related Content